Pulse Biosciences, Inc. (PLSE)
44.43
-1.16
(-2.54%)
USD |
NASDAQ |
Oct 16, 16:00
44.39
-0.04
(-0.09%)
After-Hours: 20:00
Pulse Biosciences Cash from Operations (Quarterly) : -18.71M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -18.71M |
| March 31, 2026 | -14.60M |
| December 31, 2025 | -14.76M |
| September 30, 2025 | -13.04M |
| June 30, 2025 | -12.81M |
| March 31, 2025 | -13.52M |
| December 31, 2024 | -9.144M |
| September 30, 2024 | -9.024M |
| June 30, 2024 | -8.395M |
| March 31, 2024 | -9.78M |
| December 31, 2023 | -6.776M |
| September 30, 2023 | -10.49M |
| June 30, 2023 | -9.202M |
| March 31, 2023 | -6.57M |
| December 31, 2022 | -7.965M |
| September 30, 2022 | -10.63M |
| June 30, 2022 | -12.82M |
| March 31, 2022 | -15.59M |
| December 31, 2021 | -12.69M |
| September 30, 2021 | -13.35M |
| June 30, 2021 | -16.37M |
| Date | Value |
|---|---|
| March 31, 2021 | -11.69M |
| December 31, 2020 | -9.255M |
| September 30, 2020 | -8.549M |
| June 30, 2020 | -7.939M |
| March 31, 2020 | -9.622M |
| December 31, 2019 | -9.196M |
| September 30, 2019 | -7.965M |
| June 30, 2019 | -9.694M |
| March 31, 2019 | -7.33M |
| December 31, 2018 | -6.308M |
| September 30, 2018 | -6.85M |
| June 30, 2018 | -5.72M |
| March 31, 2018 | -5.018M |
| December 31, 2017 | -3.963M |
| September 30, 2017 | -3.417M |
| June 30, 2017 | -1.208M |
| March 31, 2017 | -2.499M |
| December 31, 2016 | -2.318M |
| September 30, 2016 | -1.982M |
| June 30, 2016 | -2.289M |
| March 31, 2016 | -1.462M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Accuray, Inc. | 2.427M |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | -6.147M |
| ResMed, Inc. | 454.63M |
| Rockwell Medical, Inc. | 2.08M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.09M |
| Cash from Financing (Quarterly) | 52.10M |
| Free Cash Flow | -61.39M |
| Free Cash Flow Per Share (Quarterly) | -0.2717 |
| Free Cash Flow to Equity (Quarterly) | -18.42M |
| Free Cash Flow to Firm (Quarterly) | -18.80M |
| Free Cash Flow Yield | -2.03% |